BIOGEN INC. Notes Payable, Noncurrent
BIOGEN INC. (BIIB) had Notes Payable, Noncurrent of $6.29 billion as of 2025-12-31, per its 10-K filed 2026-02-06.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Noncurrent
us-gaap:LongTermNotesPayable · last filed 2026-02-06
- 2025-12-31: Notes Payable, Noncurrent $6.29B.
- 2024-12-31: Notes Payable, Noncurrent $4.55B.
- 2023-12-31: Notes Payable, Noncurrent $6.79B.
- 2022-12-31: Notes Payable, Noncurrent $6.28B; Notes Payable, Noncurrent as first filed $6.57B.
| Period end | Notes Payable, Noncurrent | Notes Payable, Noncurrent as first filed |
|---|---|---|
| 2025-12-31 | $6.29B 10-K · filed 2026-02-06 | |
| 2024-12-31 | $4.55B 10-K · filed 2026-02-06 | |
| 2023-12-31 | $6.79B 10-K · filed 2025-02-12 | |
| 2022-12-31 | $6.28B 10-K · filed 2024-02-14 | $6.57B 10-K · filed 2023-02-15 |
| 2021-12-31 | $7.57B 10-K · filed 2022-02-03 | |
| 2020-12-31 | $7.50B 10-K · filed 2021-02-03 | |
| 2019-12-31 | $6.00B 10-K · filed 2020-02-06 | |
| 2018-12-31 | $6.00B 10-K · filed 2019-02-06 | |
| 2017-12-31 | $6.00B 10-K · filed 2018-02-01 | |
| 2016-12-31 | $6.56B 10-K · filed 2017-02-02 | |
| 2015-12-31 | $6.56B 10-K · filed 2016-02-03 | |
| 2014-12-31 | $562.70M 10-K · filed 2015-02-04 | |
| 2013-12-31 | $567.90M 10-K · filed 2014-02-06 | |
| 2013-03-31 | $711.83M 10-Q · filed 2013-04-25 | |
| 2012-12-31 | $687.40M 10-Q · filed 2013-04-25 | |
| 2012-09-30 | $658.44M 10-Q · filed 2012-10-25 | |
| 2012-06-30 | $641.57M 10-Q · filed 2012-07-24 | |
| 2012-03-31 | $626.01M 10-Q · filed 2012-05-01 | |
| 2011-12-31 | $1.06B 10-K · filed 2013-02-05 | |
| 2011-09-30 | $1.06B 10-Q · filed 2011-10-28 | |
| 2011-06-30 | $1.06B 10-Q · filed 2011-07-26 | |
| 2011-03-31 | $1.07B 10-Q · filed 2011-04-21 | |
| 2010-12-31 | $1.07B 10-K · filed 2012-02-03 | |
| 2010-09-30 | $1.07B 10-Q · filed 2010-10-26 | |
| 2010-06-30 | $1.07B 10-Q · filed 2010-07-20 | |
| 2010-03-31 | $1.08B 10-Q · filed 2010-04-20 | |
| 2009-12-31 | $1.08B 10-K · filed 2011-02-04 | |
| 2009-09-30 | $1.09B 10-Q · filed 2009-10-21 | |
| 2009-06-30 | $1.09B 10-Q · filed 2009-07-17 | |
| 2008-12-31 | $1.09B 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |